Home › Funds › Jackson Hole Capital Partners, LLC › GILD

Jackson Hole Capital Partners, LLC position in GILD

GILEAD SCIENCES INC · Health Care

Jackson Hole Capital Partners, LLC reported holding 33,305 shares of GILD (GILEAD SCIENCES INC) in its Q1 2026 13F filing — a position valued at US$4.6M, representing 0.78% of its reported portfolio and ranking #36 among its reported holdings. Jackson Hole Capital Partners, LLC has disclosed GILD holdings in 10 of the last 11 reported quarters, going back to Q3 2023.

Latest position (Q1 2026)33.30K sh
Reported value held$4.64M
Portfolio Weight0.78%
First reportedQ3 2023
Last changeHold
Updated2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

How Jackson Hole Capital Partners, LLC's GILD position evolved

Jackson Hole Capital Partners, LLC first disclosed a stake in GILD in Q3 2023 at 18,351 shares (US$1.4M). The position peaked in Q1 2026 at 33,305 shares, worth US$4.6M. Across 10 filings, Jackson Hole Capital Partners, LLC increased the stake 5 time(s), trimmed it 2 time(s) and left it unchanged 2 time(s). The most recent filing (Q1 2026) shows 33,305 shares valued at US$4.6M. Notable position changes include a 40% increase in Q3 2024 (shares rose 11% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 18.35K $1.38M New
Q4 2023 19.59K $1.59M Add
Q1 2024 23.10K $1.69M Add
Q3 2024 32.37K $2.71M Add
Q4 2024 34.57K $3.19M Add
Q1 2025 34.09K $3.82M Reduce
Q2 2025 34.70K $3.85M Add
Q3 2025 33.24K $3.69M Reduce
Q4 2025 33.23K $4.08M Hold
Q1 2026 33.30K $4.64M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About GILD and 13F data

GILD (GILEAD SCIENCES INC) is a Health Care company. 35 other funds we track also report a position in GILD — the largest reported positions include Fidelity Management & Research (FMR) (US$8.45B), Capital World Investors (US$5.18B), Capital World Investors (US$5.18B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GILD

All GILD fund holders →

FAQ

How long has Jackson Hole Capital Partners, LLC held GILD?

Jackson Hole Capital Partners, LLC has disclosed GILD holdings in 10 of the last 11 reported quarters, going back to Q3 2023.

What is Jackson Hole Capital Partners, LLC's current position in GILD?

As of Q1 2026, Jackson Hole Capital Partners, LLC holds 33.30K shares of GILD (GILEAD SCIENCES INC), valued at $4.64M, representing 0.78% of its reported portfolio and ranking #36.

Has Jackson Hole Capital Partners, LLC been buying or selling GILD?

In the latest 13F filing (Q1 2026), Jackson Hole Capital Partners, LLC held unchanged its position in GILD. The position peaked in Q1 2026 at 33.30K shares.

Which other funds hold GILD?

Other major institutional holders of GILD include Fidelity Management & Research (FMR), Capital World Investors, Capital World Investors, among 35 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.